A drug used to treat breast cancer that has spread or that has come back within 6 months after chemotherapy. It is also being studied in the treatment of newly diagnosed breast cancer and other types of cancer. ABI-007 is a type of mitotic inhibitor. Also called nanoparticle paclitaxel, protein-bound paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation, and Abraxane.